Overview
Status
Active
Registry date
2015-08-20
Share capital
5,000.00 PLN
Registered address
297, 21-030 Radawiec Duży, Poland
Email
Financials
Total Assets
410.46
0.0% vs 2024
Revenue history
Financial insight
- The statement flags a going concern risk.
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 77 days late).
- 2025filed
- 202425/06/2025
- 202301/07/2024
- 202204/07/2023
- 202130/09/2022
- 202015/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Sylwia Katarzyna Mazurekage 38 – President of the Management Board
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sylwia Katarzyna Mazurekage 38 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Punguentsp. z o.o. | 632,090.76 USD | 78% |
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Powerpharmasp. z o.o. | – | powerpharma.eu |
FAQ
The main business activity of Balmpharm focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on August 20, 2015.
The headquarters is located at: 297, 21-030 Radawiec Duży.
The management board consists of: Sylwia Katarzyna Mazurek (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07